Are recurrent ischaemic events more common in patients with aborted myocardial infarction following thrombolytic therapy? Insights from 15869 patients from the Assent-2 trial — Claudio Fresco (2000) | RDL Network
Are recurrent ischaemic events more common in patients with aborted myocardial infarction following thrombolytic therapy? Insights from 15869 patients from the Assent-2 trial
Roxana Mehran, Philippe Gabríel Steg, Marc A. Pfeffer, Karola Jering, Brian Claggett, Eldrin F. Lewis, Christopher B. Granger, Lars Køber, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, Jean‐Lucien Rouleau, Scott D. Solomon, Grégory Ducrocq, Otávio Berwanger, Carmine G. De Pasquale, Ulf Landmesser, Mark C. Petrie, David Sim Kheng Leng, Peter van der Meer, Martin Lefkowitz,
Maria Grazia Franzosi, Eugenio Santoro, Claudio De Vita, Enrico Geraci, Antonio Lotto, Aldo Maggioni, Francesco Mauri, F Rovelli, Luigi Santoro, Luigi Tavazzi, Gianni Tognoni
Patrick W. Serruys, William Wijns, Michele L. Simmons, H. Suryapranata, J. Planellas, R. van Domburg, P. Fioretti, Pim J. de Feyter, M. V. D. Brand, Philip Hugenholtz
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.